IVP Plummets 28% as Nasdaq Delisting Looms—Is This the Final Chapter?

Summary
• Inspire Veterinary (IVP) crashes to $0.5602, down 28.44% from $0.783
• Intraday range: $0.724 high to $0.5602 low amid 7.36% turnover
• Nasdaq delisting notice triggers panic as 52W low of $0.5602 now equals current price

The animal health sector braces for a seismic shift as Inspire Veterinary’s stock implodes on the brink of Nasdaq delisting. With the company ineligible for a compliance period due to aggressive reverse splits, traders face a high-stakes reckoning. The stock’s collapse to its 52-week low underscores a dire liquidity crisis, while sector peers like Zoetis (ZTS) drift lower, signaling broader market unease.

Nasdaq Delisting Notice Sparks Panic Sell-Off
Inspire Veterinary’s 28.44% intraday freefall stems from a Nasdaq delisting notice issued on November 13, 2025, for failing the $1.00 minimum bid price requirement. The company’s repeated reverse splits—cumulative ratio of 250:1 over two years—disqualified it from the standard 180-day compliance grace period. This regulatory hammer, combined with a deteriorating balance sheet and lack of institutional support, triggered a liquidity vacuum. Traders are fleeing as the November 24 delisting date looms, with no credible turnaround plan in sight.

Animal Health Sector Steadies as Zoetis Drifts Lower
While Inspire Veterinary’s collapse is self-inflicted, the broader animal health sector remains relatively stable. Zoetis (ZTS), the sector’s bellwether, trades down 0.64% intraday, reflecting cautious sentiment but no direct contagion. IVP’s delisting is an isolated event, though its micro-cap status and lack of institutional coverage mean its struggles won’t ripple across the sector. Investors should monitor ZTS for macro cues but treat IVP as a speculative anomaly.

Technical Deterioration and Options Void Signal High-Risk Play
• RSI: 36.29 (oversold)
• MACD: -0.058 (bearish), Signal Line: -0.0498
• Bollinger Bands: Lower band at $0.654 (IVP now at $0.5602, 14% below)
• 200D MA: $1.342 (IVP at $0.5603, 58% below)

IVP’s technicals paint a terminal picture. The stock is in freefall, with RSI in oversold territory and MACD diverging sharply. Bollinger Bands show extreme weakness, while the 200-day average looms as an unattainable benchmark. With no options liquidity and a delisting clock ticking, this is a high-risk, high-reward scenario. Aggressive short-sellers might target $0.50 as a next support level, but long-term investors should avoid this asset unless a last-minute rescue materializes. The sector’s stability offers no refuge; IVP is a standalone bet.

Backtest Inspire Veterinary Stock Performance
To identify “-28 % intraday plunges” I first need to know exactly how you’d like the drop to be measured:1. Close-to-close: trading days where the closing price fell ≥ 28 % versus the previous day’s close (this is the quickest to back-test with the data I can retrieve immediately).2. High-to-low (true intraday): days where the low price was ≥ 28 % below that day’s intraday high. (This requires intraday bar data, which will take longer to pull and process.)Which definition would you prefer for this back-test on IVP?

IVP Faces Existential Crossroads—Act Fast or Exit Stage Left
Inspire Veterinary’s delisting countdown has transformed this stock into a binary bet. With no options to hedge and technicals pointing to further decay, the immediate outlook is dire. Traders must watch the November 20 hearing request deadline—approval could delay delisting but won’t fix fundamentals. Meanwhile, Zoetis (ZTS)’s -0.64% move highlights sector caution. For IVP, the path forward is clear: exit now or risk total capital erosion. The final act is unfolding—will you be in the audience or on stage?